• Noor Samavia, Parvaiz Fahed, Waheed Yasir, Anwar Tasneem, and Nasreen Syeda.
• Department of Biosciences, COMSATS University, Islamabad, Pakistan.
• Afr Health Sci. 2022 Sep 1; 22 (3): 626639626-639.

BackgroundVaccine development against emerging infections is essentially important for saving people from increasing viral infections. In developing countries, Hepatitis E (HEV) is a common infection affecting millions of people worldwide. Based on In-silico analysis, different approaches have been targeted.ObjectivesRationale of this study is to design an epitope-based vaccine candidates with the help of immunoinformatics that can predict promiscuous B-cell and T-cell epitopes of the most antigenic HEV-ORF2 capsid protein.Materials & MethodsThis study suggests potential T-cell and B-cell epitopes of the highly antigenic HEV ORF2 capsid protein while using various In-silico tools such as NCBI-BLAST, Expassy, CLC workbench, Ellipro and Discotope.ResultsPotential antigenic and immunogenic CD8+ T-cell epitopes were predicted from the global consensus sequence of ORF2-HEV. Furthermore, twenty-two linear B-cell epitopes were predicted. Among these, "SLGAGPV" at position 587-593 and "LEFRNLTPGNTNTRVSRYSS" at position 306-325 were most antigenic with antigenicity score 1.4206 and 1.3600 respectively. Discontinuous B-cell epitopes were found by three-dimensional capsid protein structure. Epitopes predicted in this study reveal high antigenicity and promiscuity for HLA classes.ConclusionCollectively, our data suggests promiscuous epitopes that can potentially acts as new candidates for the design of HEV peptide vaccine.© 2022 Samavia N et al.

10 keywords...

hide…